Treatment with Next-Generation, Liquid Embolic NeoCast™ is Pain-Free and Leads to Rapid Resorption of Chronic Subdural Hematoma
Late-Breaking Results from EMBO-02 Clinical Trial Presented at the Society of Neurointerventional Surgery Annual Meeting WALTHAM, Mass.–(BUSINESS WIRE)–Arsenal Medical, a clinical-stage company developing innovative biomaterials-based devices, today announced late-breaking data from the EMBO-02 clinical study for NeoCast™, a next-generation, shear-responsive liquid embolic treatment. In EMBO-02, NeoCast was evaluated in patients with chronic subdural hematoma (cSDH), … [Read more…]
